AllianceBernstein
TTPH

AllianceBernstein’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

AllianceBernstein’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,865
Closed -$50K – 3219
2019
Q1 		$50K Sell
1,865
-930
-33% -$23.7K ﹤0.01% 3084
2018
Q4 		$63K Hold
2,795
– – ﹤0.01% 3039
2018
Q3 		$154K Hold
2,795
– – ﹤0.01% 3033
2018
Q2 		$200K Buy
2,795
+65
+2% +$4.59K ﹤0.01% 2969
2018
Q1 		$168K Hold
2,730
– – ﹤0.01% 2893
2017
Q4 		$344K Hold
2,730
– – ﹤0.01% 2671
2017
Q3 		$373K Sell
2,730
-230
-8% -$30.8K ﹤0.01% 2682
2017
Q2 		$422K Buy
2,960
+190
+7% +$29.4K ﹤0.01% 2673
2017
Q1 		$509K Hold
2,770
– – ﹤0.01% 2532
2016
Q4 		$223K Hold
2,770
– – ﹤0.01% 2855
2016
Q3 		$212K Hold
2,770
– – ﹤0.01% 2824
2016
Q2 		$238K Buy
2,770
+468
+20% +$42.9K ﹤0.01% 2765
2016
Q1 		$213K Sell
2,302
-205
-8% -$20.5K ﹤0.01% 2705
2015
Q4 		$503K Sell
2,507
-150
-6% -$29.9K ﹤0.01% 2453
2015
Q3 		$396K Sell
2,657
-50,303
-95% -$36.9M ﹤0.01% 2570
2015
Q2 		$50.2M Buy
52,960
+539
+1% +$441K 0.04% 478
2015
Q1 		$38.4M Buy
52,421
+727
+1% +$546K 0.03% 543
2014
Q4 		$41.1M Buy
51,694
+51,624
+73,749% +$27.8M 0.03% 524
2014
Q3 		$28K Sell
70
-70
-50% -$18.7K ﹤0.01% 3158
2014
Q2 		$38K Buy
140
+133
+1,900% +$28.5K ﹤0.01% 3148
2014
Q1 		$2K Hold
7
– – ﹤0.01% 3480
2013
Q4 		$2K Sell
7
-20
-74% -$4.77K ﹤0.01% 3274
2013
Q3 		$6K Sell
27
-9
-25% -$1.57K ﹤0.01% 3198
2013
Q2 		$5K Buy
+36
New +$5.7K ﹤0.01% 3194

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

AllianceBernstein's TTPH Position: Q2 2019 in Review

AllianceBernstein sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 1,865 shares — an estimated $50K sold.

AllianceBernstein first reported a position in TTPH in Q2 2013 and held it in 24 quarters. The position peaked at $50.2M in Q2 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

  • AllianceBernstein reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • AllianceBernstein sold 1,865 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $50K.
  • AllianceBernstein first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 24 quarters.
  • AllianceBernstein's Tetraphase Pharmaceuticals, Inc. position peaked at $50.2M in Q2 2015.
  • 66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on AllianceBernstein's 13F filing for Q2 2019, filed 14 Aug 2019.